200 related articles for article (PubMed ID: 14568923)
1. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes.
Anastasi E; Campese AF; Bellavia D; Bulotta A; Balestri A; Pascucci M; Checquolo S; Gradini R; Lendahl U; Frati L; Gulino A; Di Mario U; Screpanti I
J Immunol; 2003 Nov; 171(9):4504-11. PubMed ID: 14568923
[TBL] [Abstract][Full Text] [Related]
2. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
4. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
Goudy KS; Burkhardt BR; Wasserfall C; Song S; Campbell-Thompson ML; Brusko T; Powers MA; Clare-Salzler MJ; Sobel ES; Ellis TM; Flotte TR; Atkinson MA
J Immunol; 2003 Sep; 171(5):2270-8. PubMed ID: 12928371
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
6. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent.
Pechhold K; Patterson NB; Blum C; Fleischacker CL; Boehm BO; Harlan DM
J Immunol; 2001 Feb; 166(4):2531-9. PubMed ID: 11160314
[TBL] [Abstract][Full Text] [Related]
7. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice.
Lepault F; Gagnerault MC
J Immunol; 2000 Jan; 164(1):240-7. PubMed ID: 10605017
[TBL] [Abstract][Full Text] [Related]
8. Recombinant
Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
[TBL] [Abstract][Full Text] [Related]
9. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
10. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations.
Stephens LA; Mason D
J Immunol; 2000 Sep; 165(6):3105-10. PubMed ID: 10975823
[TBL] [Abstract][Full Text] [Related]
11. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
[TBL] [Abstract][Full Text] [Related]
13. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development.
Felli MP; Maroder M; Mitsiadis TA; Campese AF; Bellavia D; Vacca A; Mann RS; Frati L; Lendahl U; Gulino A; Screpanti I
Int Immunol; 1999 Jul; 11(7):1017-25. PubMed ID: 10383933
[TBL] [Abstract][Full Text] [Related]
15. Notch3 and pTalpha/pre-TCR sustain the in vivo function of naturally occurring regulatory T cells.
Campese AF; Grazioli P; Colantoni S; Anastasi E; Mecarozzi M; Checquolo S; De Luca G; Bellavia D; Frati L; Gulino A; Screpanti I
Int Immunol; 2009 Jun; 21(6):727-43. PubMed ID: 19461123
[TBL] [Abstract][Full Text] [Related]
16. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis.
Vasu C; Dogan RN; Holterman MJ; Prabhakar BS
J Immunol; 2003 Jun; 170(11):5511-22. PubMed ID: 12759428
[TBL] [Abstract][Full Text] [Related]
17. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations.
Zipris D; Hillebrands JL; Welsh RM; Rozing J; Xie JX; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2003 Apr; 170(7):3592-602. PubMed ID: 12646622
[TBL] [Abstract][Full Text] [Related]
18. Dual genetic absence of STAT6 and IL-10 does not abrogate anti-hyperglycemic effects of Schistosoma mansoni in streptozotocin-treated diabetic mice.
Osada Y; Fujiyama T; Kamimura N; Kaji T; Nakae S; Sudo K; Ishiwata K; Kanazawa T
Exp Parasitol; 2017 Jun; 177():1-12. PubMed ID: 28363777
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice.
Bellavia D; Campese AF; Alesse E; Vacca A; Felli MP; Balestri A; Stoppacciaro A; Tiveron C; Tatangelo L; Giovarelli M; Gaetano C; Ruco L; Hoffman ES; Hayday AC; Lendahl U; Frati L; Gulino A; Screpanti I
EMBO J; 2000 Jul; 19(13):3337-48. PubMed ID: 10880446
[TBL] [Abstract][Full Text] [Related]
20. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.
Szanya V; Ermann J; Taylor C; Holness C; Fathman CG
J Immunol; 2002 Sep; 169(5):2461-5. PubMed ID: 12193715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
